Farther Finance Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$450K	Buy	7,857 +3,484	+80%	+$203K	﹤0.01%	1479
2025 Q4	$260K	Buy	4,373 +3,967	+977%	+$216K	﹤0.01%	1744
2025 Q3	$22K	Buy	406 +161	+66%	+$9.21K	﹤0.01%	2986
2025 Q2	$13.5K	Sell	245 -186	-43%	-$11K	﹤0.01%	2915
2025 Q1	$29.3K	Buy	431 +211	+96%	+$14.2K	﹤0.01%	2170
2024 Q4	$14.5K	Buy	220 +130	+144%	+$8.71K	﹤0.01%	2218
2024 Q3	$6.33K	Buy	90 +2	+2%	+$167	﹤0.01%	2554
2024 Q2	$7.23K	Sell	88 -38	-30%	-$3.16K	﹤0.01%	2213
2024 Q1	$11K	Sell	126 -22	-15%	-$1.97K	﹤0.01%	1724
2023 Q4	$14.3K	Buy	148 +112	+311%	+$9.91K	﹤0.01%	1453
2023 Q3	$3.19K	Sell	36 -9	-20%	-$801	﹤0.01%	1673
2023 Q2	$3.9K	Buy	45 +34	+309%	+$3.2K	﹤0.01%	1521
2023 Q1	$1.07K	Hold	11	–	–	﹤0.01%	1827
2022 Q4	$1.14K	Buy	+11	New	+$1.03K	﹤0.01%	1619